IFCI Q1 FY27 Results Analysis: Loan Book Stays Deeply Impaired, Profit Relies on One-Time Gain

CompoundingAI Research Updated August 11, 2026 2 min read
Negative

IFCI Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 102.64 Cr (-34.00% YoY) and PAT growth of +17.07% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 11, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 102.64 Cr (-34.00% YoY)
PAT (Q1)Rs. 8.64 Cr (+17.07% YoY)
EPS (Q1)Rs. 0.03 (+0.00% YoY)
Market capRs. 20,390.61 Cr
CMPRs. 75.71

Quarter Snapshot

IFCI's Q1FY27 results show a deeply impaired loan book (GNPA 95.68%), negative capital adequacy (-17.58% CRAR), and a standalone core loss before provisions. Profitability was entirely dependent on a one-time impairment reversal. The group consolidation plan offers a potential structural fix but remains in early stages with no timeline. Subsidiaries provide some earnings buffer, but the parent's financial position is critical.

Key Investment Insights

Key Positives

  • Impairment reversal of Rs.48.30 Cr (standalone) swung the PBT from potential loss to profit of Rs.25.36 Cr
  • Subsidiaries contributed Rs.24.88 Cr to owners' PAT, reversing a drag of Rs.8.14 Cr in Q4FY26
  • Gross NPA ratio improved marginally from 95.79% in Mar-26 to 95.68% in Jun-26
  • In-principle DFS approval received for group consolidation, which could address capital and structural issues

Risk Factors

  • CRAR at −17.58% is critically below the RBI minimum of 15%, preventing new lending
  • 95.68% of the loan book is classified as non-performing, with net NPA at 78.20%
  • Standalone core business generates a pre-provision loss of Rs.22.94 Cr, entirely dependent on impairment reversals
  • Standalone revenue declined 34% YoY due to fair value losses and lower fee income
  • Other expenses doubled YoY and employee costs rose 25% YoY, increasing cost pressure
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now